PMI Shareholder Alert: April 3, 2026 Lead Plaintiff Deadline in Picard Medical, Inc. Securities Class Action Lawsuit -- The Gross Law Firm

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Picard Medical, Inc. regarding a securities class action lawsuit, highlighting allegations of fraudulent activities and misleading statements made by the company during a specified class period [1][2]. Group 1: Allegations - The lawsuit alleges that during the class period from September 2, 2025, to October 31, 2025, Picard Medical was involved in a fraudulent stock promotion scheme that included misinformation spread via social media and impersonation of financial professionals [2]. - It is claimed that insiders and affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [2]. - The company's public statements and risk disclosures allegedly omitted critical information regarding false rumors and artificial trading activity that influenced the stock price [2]. - As a result of these actions, the positive statements made by the defendants about the company's business and prospects were deemed materially misleading and lacked a reasonable basis [2]. Group 2: Class Action Details - The deadline for shareholders to register for the class action lawsuit is April 3, 2026, and registration is encouraged to ensure participation in any potential recovery [3]. - Shareholders who register will be enrolled in a portfolio monitoring system to receive updates on the case's progress [3]. - There is no cost or obligation for shareholders to participate in the lawsuit [3]. Group 3: Law Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered losses due to deceit, fraud, and illegal business practices [4]. - The firm aims to ensure that companies adhere to responsible business practices and engage in good corporate citizenship [4]. - The firm seeks recovery for investors affected by misleading statements or omissions that led to artificial inflation of stock prices [4].